TLR7 and malignant glioma: A recent study indicated that mechanisms of sensitizing malignant glioma cells lacking galectin-1 to NK killing might relate to a decrease in the release of miR-1983, which could activate endogenous toll-like receptor 7 (TLR7) in plasmacytoid DCs as well as conventional DCs as a ligand.